These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7317687)

  • 1. Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat.
    Marshall RJ; Muir AW; Winslow E
    Br J Pharmacol; 1981 Oct; 74(2):381-8. PubMed ID: 7317687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic, electrophysiological and haemodynamic effects of prolonged oral dosing with Org 7797 in the anaesthetized rat.
    Delbressine L; Harris N; Kane KA; Muir AW; Winslow E
    J Pharm Pharmacol; 1992 Dec; 44(12):996-1000. PubMed ID: 1361566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of prolonged oral administration of a new antidysrhythmic drug (Org 6001) on coronary artery ligation dysrhythmias in conscious and anesthetized rats.
    Kane KA; Leprán I; McDonald FM; Parratt JR; Szekeres L
    J Cardiovasc Pharmacol; 1980; 2(4):411-23. PubMed ID: 6156339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the electrophysiological effects of Org 7797, disopyramide, mexiletine and propafenone in anaesthetized dogs with myocardial infarcts.
    Campbell JK; Marshall RJ; Winslow E
    Br J Pharmacol; 1991 Oct; 104(2):433-9. PubMed ID: 1797309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine.
    Komori S; Sawanobori T; Tamura K; Kane KA; Parratt JR
    Jpn J Pharmacol; 1994 Jul; 65(3):193-200. PubMed ID: 7799519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of parenteral and oral mexiletine.
    Renard M; de Hemptinne J; Gillet JM; Bernard R
    Acta Cardiol Suppl; 1980; (25):75-80. PubMed ID: 6966455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic, electrocardiographic and toxic effects of the intravenous administration of increasing doses of mexiletine in the dog. Comparison with similar effects produced by other antiarrhythmics.
    Carlier J
    Acta Cardiol Suppl; 1980; (25):81-100. PubMed ID: 6966456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide.
    Beltrame J; Aylward PE; McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1984; 6(3):483-90. PubMed ID: 6202976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anaesthetized rat.
    Marshall RJ; Muir AW; Winslow E
    Br J Pharmacol; 1981 Aug; 73(4):951-9. PubMed ID: 7272592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic effects of Org 6001 in rats: correlation with plasma and tissue drug concentrations.
    Kane K; McDonald F; Parratt J; Timmer C; Vink J
    Br J Pharmacol; 1982 Feb; 75(2):319-23. PubMed ID: 7186821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
    Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
    Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of mexiletine.
    Shanks RG
    Am Heart J; 1984 May; 107(5 Pt 2):1065-71. PubMed ID: 6372422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Org 7797 on early, late and inducible arrhythmias following coronary artery occlusion in rats and dogs.
    Winslow E; Campbell JK; Barron E; Marshall RJ; Muir AW
    Br J Pharmacol; 1991 Dec; 104(4):853-8. PubMed ID: 1810599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of mexiletine on the excitability and vulnerability of the dog ventricle (author's transl)].
    Márquez Montes J; Vera Almazán A; Esteve Alderete JJ; Puente Rodero B; Montero C; Castillo-Olivares JL
    Arch Farmacol Toxicol; 1981 Dec; 7(3):307-18. PubMed ID: 7337470
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations on haemodynamic effects of mexiletine.
    Campbell NP; Zaidi SA; Adgey AA; Patterson GC; Pantridge JF
    Br Heart J; 1979 Feb; 41(2):182-6. PubMed ID: 371646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of postligation administration of ORG 6001 and disopyramide on early ischaemia-induced arrhythmias in the anaesthetized rat.
    Marshall RJ; Muir AW; Winslow E
    Br J Pharmacol; 1982 Aug; 76(4):501-3. PubMed ID: 7104520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidysrhythmic and electrophysiological effects of a new antianginal agent, bepridil.
    Kane KA; Winslow E
    J Cardiovasc Pharmacol; 1980; 2(2):193-203. PubMed ID: 6171686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mexiletine in the management of ventricular dysrhythmias.
    Campbell NP; Pantridge JF; Adgey AA
    Eur J Cardiol; 1977 Dec; 6(4):245-58. PubMed ID: 590296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.